LENZ
LENZ Therapeutics Inc.

1,243
Mkt Cap
$510.34M
Volume
2.16M
52W High
$50.40
52W Low
$14.91
PE Ratio
-7.23
LENZ Fundamentals
Price
$15.24
Prev Close
$16.31
Open
$16.35
50D MA
$23.57
Beta
1.39
Avg. Volume
1.15M
EPS (Annual)
-$2.34
P/B
2.25
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·11h ago
News Placeholder
More News
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Hits New 1-Year Low - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Hits New 12-Month Low - What's Next...
MarketBeat·6d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ Therapeutics, Inc. - LENZ INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of LENZ...
PR Newswire·7d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 5.1% - Time to Sell?
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 5.1% - Time to Sell...
MarketBeat·16d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - What's Next?
LENZ Therapeutics (NASDAQ:LENZ) Shares Up 5% - Time to Buy...
MarketBeat·22d ago
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of "Moderate Buy" by Analysts
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the seven brokerages that are presently covering the firm, MarketBeat reports...
MarketBeat·23d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Sees Large Volume Increase - Should You Buy?
LENZ Therapeutics (NASDAQ:LENZ) Sees Strong Trading Volume - Time to Buy...
MarketBeat·26d ago
News Placeholder
Stempoint Capital LP Buys Shares of 183,912 LENZ Therapeutics, Inc. $LENZ
Stempoint Capital LP bought a new position in LENZ Therapeutics, Inc. (NASDAQ:LENZ - Free Report) in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and...
MarketBeat·30d ago
News Placeholder
LENZ Therapeutics (NASDAQ:LENZ) Trading Down 6.3% - Here's What Happened
LENZ Therapeutics (NASDAQ:LENZ) Stock Price Down 6.3% - Time to Sell...
MarketBeat·1mo ago
News Placeholder
LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Consensus Rating of "Moderate Buy" by Brokerages
LENZ Therapeutics, Inc. (NASDAQ:LENZ - Get Free Report) has earned an average recommendation of "Moderate Buy" from the seven research firms that are currently covering the stock, Marketbeat reports...
MarketBeat·2mo ago
<
1
2
...
>

Latest LENZ News

View

Advertisement|Remove ads.

Advertisement|Remove ads.